Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting.More information
SolutionsPortfolio ENS-002 For Atopic DermatitisCB-002 For Calm, Balanced SkinENS-003 For Vaginal Yeast Infections
Technology
Contact

Tap into the microbial world.

We measure, map, and harness the microbial world to create best-in-class products. Welcome to a new generation of efficacy—through ecology.
Solutions

Reliable products powered by
microbial ecology.

The biggest challenge in microbe-based products? Making them work outside the lab. Concerto’s deep ecological insights translate to real-world efficacy for skincare issues, chronic disease, nutrition, and more.

Expore our Products
Technology

The right data
at AI scale.

Microbial communities are complex. We make them predictable and engineerable. kChip experimentally generates vast ecological datasets, and our kAI model learns from them—mapping interactions, predicting behavior, and enabling the smartest microbial products.

Latest News & Press
From Concerto 1 29 2025
Concerto Biosciences Announces Appointment of Dr. Stewart Campbell to Board of Directors
Dermatology Times 11 20 2024
Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis
MSN 11 20 2024
Concerto doses first subject in Phase I trial of ENS-002 for atopic dermatitis
See All News

Harness microbial ecology with Concerto to develop new, transformative products. 

Partner With Us

Microbes, like humans, are stronger together than they ever could be alone.
Visit Us

750 Main Street

Cambridge, MA 02139

concerto-biosciences@concertobioinfo@concertobio.com
© 2025 Concerto Biosciences, Inc. All rights reserved.